Autism spectrum disorder (ASD) is characterised by impairments in social relating, which have been linked to abnormal activation within ‘social brain’ networks that include dorsomedial prefrontal cortex (dmPFC). Despite a high prevalence (currently 1 in 68 children), at present there are no validated biomedical treatments for ASD that target core symptoms. Across two studies, we investigated whether high-frequency (5 Hz) stimulation of bilateral dmPFC, using a deep rTMS coil to achieve the necessary depth of stimulation, could induce clinical, cognitive, and neurobiological changes among ‘high-functioning’ adults with ASD. Study One involved a randomised, sham-controlled clinical trial of deep rTMS to bilateral dmPFC in 28 adults with ASD. Participants received active or sham deep rTMS each weekday for two weeks. Clinical and cognitive assessments were conducted before, after, and one-month following the treatment phase. There was a significant decrease in self-reported clinical ratings of social impairment for those in the active condition, but no change for participants allocated to sham stimulation. Study Two was an open-label study where 12 adults with ASD received 16 active treatments over 4 weeks. Participants underwent positron emission tomography (PET) to assess brain glucose metabolism before and after the treatment course, while clinical and cognitive assessments were conducted before, after, 1-month, 3-months, and 6-months following treatment. Preliminary findings indicate a number of clinical and cognitive improvements, and associated changes in neural activity. These data provide preliminary support for the safety and efficacy of deep rTMS to dmPFC in ASD, and suggest effects on neural networks that support the integration and understanding of social information.
|Original language||English GB|
|Journal||Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation|
|State||Published - 2015|